These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18977823)

  • 41. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
    Nakamura T
    Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S
    Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
    Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil.
    da Silva JL; Primo JR; de Oliveira Mde F; Batista Eda S; Moreno-Carvalho O; Farré L; Bittencourt AL
    J Clin Virol; 2013 Oct; 58(2):482-5. PubMed ID: 23932323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hormonal and Psychogenic Risk Factors for Erectile Dysfunction in Men with HTLV-1.
    de Oliveira CJV; Carneiro Neto JA; Andrade RCP; de La Glória Orge M; Liberato de Matos SNF; Rocha PN; Marcelino de Carvalho Filho E
    J Sex Med; 2019 Nov; 16(11):1763-1768. PubMed ID: 31521570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A cluster of HTLV-1 associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution.
    Kayembe K; Goubau P; Desmyter J; Vlietinck R; Carton H
    J Neurol Neurosurg Psychiatry; 1990 Jan; 53(1):4-10. PubMed ID: 2303831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long Terminal Repeat 5' Region from Patients with Tropical Spastic Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy and Asymptomatic Carriers.
    Rego FF; de Oliveira T; Giovanetti M; Galvão-Castro B; Gonçalves Mde S; Alcantara LC
    AIDS Res Hum Retroviruses; 2016 Mar; 32(3):279-83. PubMed ID: 26472535
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HTLV-1 and HIV-2 infection are associated with increased mortality in a rural West African community.
    van Tienen C; Schim van der Loeff M; Peterson I; Cotten M; Andersson S; Holmgren B; Vincent T; de Silva T; Rowland-Jones S; Aaby P; Whittle H
    PLoS One; 2011; 6(12):e29026. PubMed ID: 22194980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maternal proviral load and vertical transmission of human T cell lymphotropic virus type 1 in Guinea-Bissau.
    van Tienen C; McConkey SJ; de Silva TI; Cotten M; Kaye S; Sarge-Njie R; da Costa C; Gonçalves N; Parker J; Vincent T; Jaye A; Aaby P; Whittle H; Schim van der Loeff M
    AIDS Res Hum Retroviruses; 2012 Jun; 28(6):584-90. PubMed ID: 22066980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection.
    Rafatpanah H; Pravica V; Faridhosseini R; Tabatabaei A; Ollier W; Poulton K; Thomson W; Hutchinson I
    Iran J Immunol; 2007 Jun; 4(2):94-100. PubMed ID: 17652849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HTLV-1 and tropical spastic paraparesis. 2. The human T-cell lymphotropic virus type 1.
    Weber J
    Trans R Soc Trop Med Hyg; 1989; 83(6):729-31. PubMed ID: 2617642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-I carriers.
    Castro NM; Rodrigues W; Freitas DM; Muniz A; Oliveira P; Carvalho EM
    Urology; 2007 May; 69(5):813-8. PubMed ID: 17482910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1.
    Pinheiro SR; Martins-Filho OA; Ribas JG; Catalan-Soares BC; Proietti FA; Namen-Lopes S; Brito-Melo GE; Carneiro-Proietti AB;
    Am J Ophthalmol; 2006 Nov; 142(5):811-15. PubMed ID: 16989761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis.
    Gotuzzo E; Cabrera J; Deza L; Verdonck K; Vandamme AM; Cairampoma R; Vizcarra D; Cabada M; Narvarte G; De las Casas C
    Clin Infect Dis; 2004 Oct; 39(7):939-44. PubMed ID: 15472843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vestibular-evoked myogenic potential (VEMP) to evaluate cervical myelopathy in human T-cell lymphotropic virus type I infection.
    Felipe L; Gonçalves DU; Santos MA; Proietti FA; Ribas JG; Carneiro-Proietti AB; Lambertucci JR
    Spine (Phila Pa 1976); 2008 May; 33(11):1180-4. PubMed ID: 18469690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Keratoconjunctivitis sicca of human T cell lymphotropic virus type 1 (HTLV-1) infected individuals is associated with high levels of HTLV-1 proviral load.
    Castro-Lima Vargens C; Grassi MF; Boa-Sorte N; Rathsam-Pinheiro RH; Olavarria VN; de Almeida Kruschewsky R; Galvão-Castro B
    J Clin Virol; 2011 Nov; 52(3):177-80. PubMed ID: 21868282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients.
    Talledo M; López G; Huyghe JR; Verdonck K; Adaui V; González E; Best I; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    J Med Virol; 2010 Mar; 82(3):460-6. PubMed ID: 20087941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Peruvian family with a high burden of HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Alvarez C; Verdonck K; Tipismana M; Gotuzzo E
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26392440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.